These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11737313)

  • 1. Papillary carcinoma of the thyroid: a tumour still with no benign neoplastic counterpart.
    Stephenson TJ
    Histopathology; 2001 Nov; 39(5):536-8. PubMed ID: 11737313
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnosis of the follicular variant of papillary thyroid carcinoma. Significance of immunohistochemistry].
    Guyétant S; Michalak S; Valo I; Saint-André JP
    Ann Pathol; 2003 Feb; 23(1):11-20. PubMed ID: 12743496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of cytokeratins and ret in thyroid papillary carcinoma].
    Zhou WX; Xiao Y; Liu TH; Luo YF; Cao JL
    Zhonghua Bing Li Xue Za Zhi; 2003 Dec; 32(6):530-3. PubMed ID: 14761598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular adenoma with papillary architecture: a lesion mimicking papillary thyroid carcinoma.
    Mai KT; Landry DC; Thomas J; Burns BF; Commons AS; Yazdi HM; Odell PF
    Histopathology; 2001 Jul; 39(1):25-32. PubMed ID: 11454041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RET/PTC activation in hyalinizing trabecular tumors of the thyroid.
    Papotti M; Volante M; Giuliano A; Fassina A; Fusco A; Bussolati G; Santoro M; Chiappetta G
    Am J Surg Pathol; 2000 Dec; 24(12):1615-21. PubMed ID: 11117781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer.
    Fusco A; Chiappetta G; Hui P; Garcia-Rostan G; Golden L; Kinder BK; Dillon DA; Giuliano A; Cirafici AM; Santoro M; Rosai J; Tallini G
    Am J Pathol; 2002 Jun; 160(6):2157-67. PubMed ID: 12057919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes.
    Tallini G; Santoro M; Helie M; Carlomagno F; Salvatore G; Chiappetta G; Carcangiu ML; Fusco A
    Clin Cancer Res; 1998 Feb; 4(2):287-94. PubMed ID: 9516913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The quest for a magic tumor marker: continuing saga in the diagnosis of the follicular lesions of thyroid.
    Baloch ZW; LiVolsi VA
    Am J Clin Pathol; 2002 Aug; 118(2):165-6. PubMed ID: 12162672
    [No Abstract]   [Full Text] [Related]  

  • 9. Ret oncogene protein expression in papillary thyroid carcinoma and related lesions.
    Mai KT; Landry DC; Thomas J; Yazdi HM; Perkins DG; Odell PF
    Tumori; 2001; 87(3):166-72. PubMed ID: 11504372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ret oncogene activation in papillary thyroid carcinoma: prevalence and implication on the histological parameters.
    Lam AK; Montone KT; Nolan KA; Livolsi VA
    Hum Pathol; 1998 Jun; 29(6):565-8. PubMed ID: 9635675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of TTF-1 in thyroid tumors originating from follicular epithelium and its correlation with expression of RET, galectin-3 and mucin-1 genes].
    Chen Y; Zhu M; Zhou X; Lin W; Ni C; Li F; Zhang S; Gong Z
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):257-61. PubMed ID: 11953175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sporadic ret-rearranged papillary carcinoma of the thyroid: a subset of slow growing, less aggressive thyroid neoplasms?
    Soares P; Fonseca E; Wynford-Thomas D; Sobrinho-Simões M
    J Pathol; 1998 May; 185(1):71-8. PubMed ID: 9713362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical diagnosis of papillary thyroid carcinoma.
    Cheung CC; Ezzat S; Freeman JL; Rosen IB; Asa SL
    Mod Pathol; 2001 Apr; 14(4):338-42. PubMed ID: 11301350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunostaining for ret oncogene proteins in papillary thyroid carcinoma: a correlation of ret immunoreactivity and potential of lymph node metastasis.
    Mai KT; Vaccani JP; Thomas J; Odell PF
    Thyroid; 2001 Sep; 11(9):859-63. PubMed ID: 11575855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpretation of RET immunostaining in follicular lesions of the thyroid.
    Cerilli LA; Mills SE; Rumpel CA; Dudley TH; Moskaluk CA
    Am J Clin Pathol; 2002 Aug; 118(2):186-93. PubMed ID: 12162676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Ret/PTC1, -2, -3, -delta3 and -4 in German papillary thyroid carcinoma.
    Mayr B; Pötter E; Goretzki P; Rüschoff J; Dietmaier W; Hoang-Vu C; Dralle H; Brabant G
    Br J Cancer; 1998 Mar; 77(6):903-6. PubMed ID: 9528832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular, papillary, and "hybrid" carcinomas of the thyroid.
    Castro P; Fonseca E; Magalhães J; Sobrinho-Simões M
    Endocr Pathol; 2002; 13(4):313-20. PubMed ID: 12665649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Papillary and vesicular carcinoma of the thyroid: diagnostic problems and new data].
    Belleannee G; Trouette H; De Mascarel A
    Ann Pathol; 2000; 20 Suppl():S37-9. PubMed ID: 11261295
    [No Abstract]   [Full Text] [Related]  

  • 19. How familial cancer genes and environmentally induced oncogenes have changed the endocrine landscape.
    Asa SL
    Mod Pathol; 2001 Mar; 14(3):246-53. PubMed ID: 11266533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas.
    Jhiang SM; Sagartz JE; Tong Q; Parker-Thornburg J; Capen CC; Cho JY; Xing S; Ledent C
    Endocrinology; 1996 Jan; 137(1):375-8. PubMed ID: 8536638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.